|

Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in Diabetes

RECRUITINGN/ASponsored by Matthew Allemang
Actively Recruiting
PhaseN/A
SponsorMatthew Allemang
Started2023-01-04
Est. completion2026-06
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT04696159

Summary

This study will assess changes in glycemic control in 40 patients with diabetes who undergo per-oral pyloromyotomy (POP) for medically refractory gastroparesis.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Patients 18 years of age and older
2. Patients with gastroparesis with an average HbA1c\> 7.5% over the past 3 months
3. Patient that have a diagnosis of gastroparesis established by documented delayed gastric emptying by either a wireless motility capsule study or a nuclear gastric emptying study, with no evidence of gastric obstruction.
4. Patients are able to complete all study requirements

Exclusion Criteria:

1. Patients \<18 years of age
2. Patients with gastroparesis with an average HbA1c\< 7.5% over the past 3 months
3. Patients unable or refuse to complete the study requirements
4. Patients who are unable or refuse to wear a CGM sensor
5. Patients with insulin pumps
6. Patients who already use a CGM

Conditions4

DiabetesDiabetes MellitusGastroparesisGastroparesis With Diabetes Mellitus

Locations1 site

Cleveland Clinic Foundation
Cleveland, Ohio, 44195
Mathew Allemang, MD216 491-7861ALLEMAM@ccf.org

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.